Johns Hopkins Study Supports Potential for Injectable 'Chemical Vaccine' for Malaria Using Atovaquone
October 21, 2023
October 21, 2023
BALTIMORE, Maryland, Oct. 21 (TNSres) -- Johns Hopkins University's Bloomberg School of Public Health issued the following news release:
* * *
Researchers demonstrate in mouse model that key mutation that renders malaria parasites resistant to atovaquone also makes them non-transmissible via mosquitoes.
* * *
Johns Hopkins researchers looking to develop a long-acting, injectable malaria preventive using atovaquone have shown in a new study that . . .
* * *
Researchers demonstrate in mouse model that key mutation that renders malaria parasites resistant to atovaquone also makes them non-transmissible via mosquitoes.
* * *
Johns Hopkins researchers looking to develop a long-acting, injectable malaria preventive using atovaquone have shown in a new study that . . .